de Yébenes JG - Search Results

1

López-Sendón J, Mena MA, de Yébenes JG. López-Sendón J, et al. Among authors: de yebenes jg. Expert Opin Drug Saf. 2013 Jul;12(4):487-96. doi: 10.1517/14740338.2013.787065. Epub 2013 Mar 31. Expert Opin Drug Saf. 2013. PMID: 23540800 Review.

2

Drug-induced parkinsonism.

Mena MA, de Yébenes JG. Mena MA, et al. Among authors: de yebenes jg. Expert Opin Drug Saf. 2006 Nov;5(6):759-71. doi: 10.1517/14740338.5.6.759. Expert Opin Drug Saf. 2006. PMID: 17044803 Review.

3

Drug-induced parkinsonism in the elderly: incidence, management and prevention.

López-Sendón JL, Mena MA, de Yébenes JG. López-Sendón JL, et al. Among authors: de yebenes jg. Drugs Aging. 2012 Feb 1;29(2):105-18. doi: 10.2165/11598540-000000000-00000. Drugs Aging. 2012. PMID: 22250585 Review.

4

Trehalose protects from aggravation of amyloid pathology induced by isoflurane anesthesia in APP(swe) mutant mice.

Perucho J, Casarejos MJ, Gomez A, Solano RM, de Yébenes JG, Mena MA. Perucho J, et al. Among authors: de yebenes jg. Curr Alzheimer Res. 2012 Mar;9(3):334-43. doi: 10.2174/156720512800107573. Curr Alzheimer Res. 2012. PMID: 22272607

5

Trehalose reverses cell malfunction in fibroblasts from normal and Huntington's disease patients caused by proteosome inhibition.

Fernandez-Estevez MA, Casarejos MJ, López Sendon J, Garcia Caldentey J, Ruiz C, Gomez A, Perucho J, de Yebenes JG, Mena MA. Fernandez-Estevez MA, et al. Among authors: de yebenes jg. PLoS One. 2014 Feb 25;9(2):e90202. doi: 10.1371/journal.pone.0090202. eCollection 2014. PLoS One. 2014. PMID: 24587280 Free PMC article.

6

Cinnarizine-induced parkinsonism in primates.

García Ruiz PJ, Mena MA, Peñafiel N, De Yébenes JG. García Ruiz PJ, et al. Among authors: de yebenes jg. Clin Neuropharmacol. 1992 Apr;15(2):152-4. doi: 10.1097/00002826-199204000-00010. Clin Neuropharmacol. 1992. PMID: 1375537

7

Continuous intracerebroventricular infusion of dopamine and dopamine agonists through a totally implanted drug delivery system in animal models of Parkinson's disease.

de Yebenes JG, Fahn S, Jackson-Lewis V, Jorge P, Mena MA, Reiriz J. de Yebenes JG, et al. J Neural Transm Suppl. 1988;27:141-60. doi: 10.1007/978-3-7091-8954-2_13. J Neural Transm Suppl. 1988. PMID: 3165432

8

Side effects of the catechol-O-methyl-transferase inhibitor Ro 40-7592 in rabbits.

Garrido JM, Mena MA, Correa C, Herraras O, Jorge P, Leenders K, Antonini A, Günther I, Psylla M, de Yébenes JG. Garrido JM, et al. Among authors: de yebenes jg. Clin Neuropharmacol. 1994 Jun;17(3):270-6. doi: 10.1097/00002826-199406000-00006. Clin Neuropharmacol. 1994. PMID: 9316672

9

The multiple mechanisms of amyloid deposition: the role of parkin.

Mena MA, Rodríguez-Navarro JA, de Yébenes JG. Mena MA, et al. Among authors: de yebenes jg. Prion. 2009 Jan-Mar;3(1):5-11. doi: 10.4161/pri.3.1.8122. Epub 2009 Jan 9. Prion. 2009. PMID: 19270506 Free PMC article. Review.

10

Neurotrophic factors for the investigation and treatment of movement disorders.

De Yébenes JG, Sánchez M, Mena MA. De Yébenes JG, et al. Neurotox Res. 2003;5(1-2):119-38. doi: 10.1007/BF03033377. Neurotox Res. 2003. PMID: 12832227 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

126 results

Search Page